CAPR vs FRT · $1.62B cap vs rev $1.28B
Capricor Therapeutics Inc (CAPR) versus FRT (FRT) — a side-by-side from cached financials, not a winner call.
Capricor Therapeutics Inc (CAPR) is a biotechnology company listed on NASDAQ.
FRT (FRT) common stock.
Latest reported CAPR revenue for 2025-12-31 was $0. Net income was -$105.0M. CAPR currently screens at market cap $1.62B.
Latest reported FRT revenue for 2025-12-31 was $1.28B. Net income was $411.1M. Revenue was up 6.4% from 2024-12-31 to 2025-12-31. FRT currently screens at market cap $0.
CAPR currently screens at market cap $1.62B. FRT currently screens at market cap $0.
Not investment advice. Open the CAPR and FRT stock pages for the full models.
Not investment advice.